New USDA Harvest Projections Down from 2018

Nov 11, 2019

Based on November 1 conditions, Nebraska's 2019 corn crop is forecast at 1.77 billion bushels, down 1% from last year's production, according to the USDA's National Agricultural Statistics Service. Area to be harvested for grain, at 9.75 million acres, is up 5% from a year ago. Yield is forecast at 182 bushels per acre,

down 10 bushels from last year.

Soybean production is forecast at 282 million bushels, down 13% from last year. Area for harvest, at 4.95 million acres, is 11% below 2018. Yield is forecast at 57 bushels per acre, down 1 bushel from last year.

Sorghum production is forecast at 13.7 million bushels, down 14% from last year. Area for harvest, at 140,000 acres, is 18% below 2018. Yield is forecast at 98 bushels per acre, up 4 bushels from last year.

Sugarbeet production is forecast at 1.21 million tons, down 14% from last year. Area for harvest, at 43,600 acres, is down 1% from 2018. Yield is forecast at 27.8 tons per acre, down 4.1 tons from last year.

Potato acres of 20,000 were planted in 2019, up 3% from last year. Harvested acreage set at 19,700 acres, is up 2% from last year. Production is forecast at 9.26 million cwt, down slightly from last year. Yield is forecast at 470 cwt per acre, down 10 cwt from last year.

Source : unl.edu

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.